Evidence map›Paper›PMID 39912614›Full record

ArticleDermatology reports2025

Teledermatology: Canadian dermatologists' practice patterns, perceived challenges, and future recommendations.

Sidra Sarfaraz, Tarek Turk, Samuel A J Lowe, Luvneet Verma, Marlene Dytoc

Abstract read
In one paragraph

Article in Dermatology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sidra SarfarazDepartment of Medicine, Division of Dermatology, The Ottawa Hospital, University of Ottawa, Ontario.
Tarek TurkFaculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada; Department of Dermatology and Venereology, Ministry of Health, Damascus.
Samuel A J LoweSchool of Public Health, University of Alberta, Edmonton.ORCID 0000-0003-0196-3768
Luvneet VermaDivision of Dermatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton.ORCID 0009-0009-7302-6029
Marlene DytocDivision of Dermatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of teledermatology has increased significantly in recent years. The objective of this study was to determine Canadian dermatologists' and dermatology residents' perspectives on teledermatology. An online survey was created to determine participants' teledermatology practice patterns and their perception of the challenges, education, training, and research in teledermatology. The survey was distributed through the Canadian Dermatology Association and by administrative staff at Canadian Dermatology departments. A total of 33 respondents completed the survey: 66.7% of respondents started using teledermatology during the COVID-19 pandemic, and 93.8% reported that teledermatology accounted for 0-25% of their practice. Convenience, access, and safety were identified as the primary advantages of teledermatology. Teledermatology was mainly utilized for medication monitoring or refills and to assess, manage, or follow up on dermatitis, other chronic inflammatory conditions, and pre-diagnosed dermatologic conditions. Poor photo quality (32.3%) and the inability to conduct physical examinations or accurately diagnose conditions (74.2%) were reported as significant challenges. Respondents recommended education on the medicolegal considerations of teledermatology and research on how teledermatology compares to in-person consultations. Overall, teledermatology improves convenience, access to care, and safety for both patients and healthcare professionals. However, addressing challenges related to physical examinations, accurate diagnoses, and photo quality is essential for optimal care delivery.

Identifiers

PMID39912614
PMCPMC12522188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.